Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine)

International Journal of Pharmaceutics

Volumn 341, Issue 1-2, 2007, Pages 26-34

  Javadzadeh, Yousef ^a,b   Jafari Navimipour, Baharak ^a   Nokhodchi, Ali ^b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Carbamazepine; Dissolution rate; Liquisolid tablets; Polymorphic changes

Indexed keywords

CARBAMAZEPINE; DRUG CARRIER; MACROGOL; METHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE; POVIDONE IODINE; SILICON DIOXIDE;

ARTICLE; COMPRESSION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG FORMULATION; HUMIDITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLUBILITY; TABLET; X RAY CRYSTALLOGRAPHY;

ADSORPTION; CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMAZEPINE; CELLULOSE; CENTRAL NERVOUS SYSTEM AGENTS; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; DRUG CARRIERS; DRUG STABILITY; EXCIPIENTS; HUMIDITY; KINETICS; LACTOSE; METHYLCELLULOSE; POLYETHYLENE GLYCOLS; POVIDONE; SILICON DIOXIDE; SODIUM CHANNEL BLOCKERS; SOLUBILITY; SOLVENTS; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; WATER;

EID: 34447641982     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.03.034     Document Type: Article

References (21)

1. In: Abdou H.M. (Ed). Dissolution, Bioavailability and Bioequivalence (1989), Mack Pub. Co. pp. 53-72
2. Aguiar A.J., Zelmer A.J., and Kinkel A.W. Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt. J. Pharm. Sci. 56 (1979) 1243-1252
3. Bolourtchian N., Nokhodchi A., and Dinarvand R. The effect of solvent and crystallization conditions on habit modification of carbamazepine. Daru 9 (2001) 12-22
4. Ceolin R., Toscani S., Gardette M.F., Agafonov V.N., Dyyabchenko B., and Bachet B. X-ray characterization of the triclinic polymorph of carbamazepine. J. Pharm. Sci. 86 (1997) 1062-1065
5. Costa P. An alternative method to the evaluation of similarity factor in dissolution testing. Int. J. Pharm. 220 (2001) 77-83
6. Finholt P., and Solvang S. Dissolution kinetics of drugs in human gastric juice the role of surface tension. J. Pharm. Sci. 57 (1968) 1322-1326
7. Grzesiak A.L., Lang M., Kim K., and Matzger A.J. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J. Pharm. Sci. 92 (2003) 2260-2271
8. Himes V.L., Mighell A.D., and De Camp W.H. Structure of carbamazepine 5Hdibenz [b,f]azepine-5-carboxamide. Acta Crystallogr. B 37 (1981) 2242-2245
9. Javadzadeh Y., Siahi M.R., Barzegar Jalali M., and Nokhodchi A. Enhancement of Dissolution Rate of Piroxicam Using Liquisolid Compacts 60 (2005), IL Farmaco pp. 361-365
10. Javadzadeh, Y., Siahi, M.R., Asnaashari, S., Nokhodchi, A., 2007. An investigation on physicochemical properties of piroxicam liquisolid compacts. Drug Dev. Technol. (in press).
11. Kapsi S.G., and Ayres J.W. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int. J. Pharm. 229 (2001) 193-203
12. Lin S.L., Menig J., and Lachman L. Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs. J. Pharm. Sci. 57 (1968) 2143-2146
13. Lowes M.M.L., Caira M.R., and Lotter A.P. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. J. Pharm. Sci. 76 (1987) 744-752
14. Martindale. The Complete Drug Reference. 32th ed. (1999), The Pharmaceutical Press, London P 1473
15. Nokhodchi A., Bolourtchian N., and Dinarvand R. Dissolution and mechanical behaviors of recrystallized carbamazepine from alcohol solution in the presence of additives. J. Crystal Growth 274 (2005) 573-584
16. Nokhodchi A., Javadzadeh Y., Siahi M.R., and Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharmaceut. Sci. 8 (2005) 18-25
17. Simonelli A.P., Mehta S.C., and Higuchi W.I. Dissolution rates of high energy sulfathiazole-povidon coprecipitates: II: characterization of form of drug controlling its dissolution rate solubility studies. J. Pharm. Sci. 65 (1976) 355-361
18. Spireas S., and Sadu S. Enhancement of Prednisolone dissolution properties using liquisolid compacts. Int. J. Pharm. 166 (1998) 177-188
19. Spireas S., Sadu S., and Grover R. In vitro release evaluation of hydrocortisone liquisolid tablets. J. Pharm. Sci. 87 (1998) 867-872
20. Spireas S., Wang T., and Grover R. Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts. Drug Dev. Ind. Pharm. 25 (1999) 163-168
21. Usui F., Maeda K., kusai A., Ikeda K., Nishimura K., and Yamato K. Inhibitory effect of water-soluble polymers on precipitation of RS-8359. Int. J. Pharm. 154 (1997) 59-66